Further studies revealed that TRIM15 promotes tumor progression by mediating the ubiquitination and subsequent degradation of YY2, disrupting lipid and energy metabolism regulation in EAC cells by inhibiting FOXRED1 transcription. Here, YY2 is linked to neoplasm.